Literature DB >> 9529164

Effects of constitutive overexpression of insulin-like growth factor-1 on the mechanical characteristics and molecular properties of ventricular myocytes.

G Redaelli1, A Malhotra, B Li, P Li, E H Sonnenblick, P A Hofmann, P Anversa.   

Abstract

Recently, insulin-like growth factor-1 (IGF-1) has been claimed to positively influence the cardiac performance of the decompensated heart. On this basis, the effects of constitutive overexpression of IGF-1 on the mechanical behavior of myocytes were examined in transgenic mice in which the cDNA for the human IGF-1B was placed under the control of a rat alpha-myosin heavy chain promoter. In mice heterozygous for the transgene and in nontransgenic littermates at 2.5 months of age, the alterations in Ca2+ sensitivity of tension development, unloaded shortening velocity, and sarcomere compliance were measured in skinned myocytes. The quantities and state of phosphorylation of myofilament proteins in these enzymatically dissociated ventricular myocytes were also examined. The overexpression of IGF-1 was characterized by a nearly 15% reduction in myofilament isometric tension at submaximum Ca2+ levels in the physiological range, whereas developed tension at maximum activation was unchanged. In contrast, unloaded velocity of shortening was increased 39% in myocytes from transgenic mice. Moreover, resting tension in these cells was reduced by 24% to 33%. Myocytes from nontransgenic mice pretreated with IGF-1 failed to reveal changes in myofilament Ca2+ sensitivity and unloaded velocity of shortening. The quantities of C protein, troponin I, and myosin light chain-2 were comparable in transgenic and nontransgenic mice, but their endogenous state of phosphorylation increased 117%, 100%, and 100%, respectively. Troponin T content was not altered, and myosin isozymes were essentially 100% V1 in both groups of mice. In conclusion, constitutive overexpression of IGF-1 may influence positively the performance of myocytes by enhancing shortening velocity and cellular compliance.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9529164     DOI: 10.1161/01.res.82.5.594

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  6 in total

1.  Cardiac overexpression of insulin-like growth factor 1 attenuates chronic alcohol intake-induced myocardial contractile dysfunction but not hypertrophy: Roles of Akt, mTOR, GSK3beta, and PTEN.

Authors:  Bingfang Zhang; Subat Turdi; Quan Li; Faye L Lopez; Anna R Eason; Piero Anversa; Jun Ren
Journal:  Free Radic Biol Med       Date:  2010-08-01       Impact factor: 7.376

2.  Insulin-like growth factor I and II preserve myocardial structure in postinfarct swine.

Authors:  A A Kotlyar; Z Vered; I Goldberg; P Chouraqui; D Nas; E Fridman; Z Chen-Levy; S Fytlovich; G Sangiorgi; L G Spagnoli; A Orlandi; N Savion; M Eldar; M Scheinowitz
Journal:  Heart       Date:  2001-12       Impact factor: 5.994

3.  bcl-2 overexpression promotes myocyte proliferation.

Authors:  Federica Limana; Konrad Urbanek; Stefano Chimenti; Federico Quaini; Annarosa Leri; Jan Kajstura; Bernardo Nadal-Ginard; Seigo Izumo; Piero Anversa
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-30       Impact factor: 11.205

4.  Chronic treatment with insulin-like growth factor I enhances myocyte contraction by upregulation of Akt-SERCA2a signaling pathway.

Authors:  Song-Jung Kim; Maha Abdellatif; Sharat Koul; George J Crystal
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-05-02       Impact factor: 4.733

Review 5.  Insulin signaling pathways and cardiac growth.

Authors:  Brian J DeBosch; Anthony J Muslin
Journal:  J Mol Cell Cardiol       Date:  2008-03-19       Impact factor: 5.000

6.  Insulin-like growth factor 1 treatment of MSCs attenuates inflammation and cardiac dysfunction following MI.

Authors:  Jun Guo; Dong Zheng; Wen-feng Li; Hai-rui Li; Ai-dong Zhang; Zi-cheng Li
Journal:  Inflammation       Date:  2014-12       Impact factor: 4.092

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.